CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25− T cells in adoptive transfer colitis (Q56798235)

0 references

author name string

Nanna Ny Kristensen

0 references

Monika Gad

0 references

Bao Lu

0 references

Craig Gerard

0 references

Mogens Helweg Claesson

Inflammatory Bowel Diseases

0 references

publication date

May 2006

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

374-381

0 references

cites work

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

New pathogenetic insights into the sarcoid granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Chemokine receptor CXCR3 expression in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

The immunology of mucosal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Recent developments in the immunology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Foxp3 and natural regulatory T cells: key to a cell lineage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000217337.15442.E1